Ajanta Pharma Limited — Others, 08-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Ajanta Pharma has announced a certificate from its Registrar and Share Transfer Agent confirming that all securities received for dematerialisation in the recent quarter were processed timely and correctly. Share certificates have been verified, mutilated, and cancelled, with depositories recorded as the registered owners as required. This update ensures smoother securities handling and reflects sound shareholding management, providing clarity and confidence to investors about the company’s compliance with share demat procedures.